Scinovex
review Open AccessTop 10% cited

Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence

Journal of Clinical Medicine · 2020 · Vol. 9(5) · pp. 1417–1417
Celestino SarduJessica GambardellaMarco Bruno MorelliXujun WangRaffaele MarfellaGaetano Santulli

Abstract

The symptoms most commonly reported by patients affected by coronavirus disease (COVID-19) include cough, fever, and shortness of breath. However, other major events usually observed in COVID-19 patients (e.g., high blood pressure, arterial and venous thromboembolism, kidney disease, neurologic disorders, and diabetes mellitus) indicate that the virus is targeting the endothelium, one of the largest organs in the human body. Herein, we report a systematic and comprehensive evaluation of both clinical and preclinical evidence supporting the hypothesis that the endothelium is a key target organ in COVID-19, providing a mechanistic rationale behind its systemic manifestations.

COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Cardiovascular Disease and AdiposityMedicineDiabetes mellitusCoronavirus disease 2019 (COVID-19)ThrombosisIntensive care medicineDiseaseEndotheliumKidney diseaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Venous thrombosis

Funding

  • American Heart Association
  • National Institutes of Health
Citations
568
FWCI
12.78
field-weighted impact
References
270
Percentile
99%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.